UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000042095 |
|---|---|
| Receipt number | R000048041 |
| Scientific Title | Pharmacokinetics study of food ingredient.(SIC-2020-05-SHKBSE) |
| Date of disclosure of the study information | 2020/10/28 |
| Last modified on | 2024/10/29 15:36:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Pharmacokinetics study of food ingredient.(SIC-2020-05-SHKBSE)
Acronym
Pharmacokinetics study of food ingredient.(SIC-2020-05-SHKBSE)
Scientific Title
Pharmacokinetics study of food ingredient.(SIC-2020-05-SHKBSE)
Scientific Title:Acronym
Pharmacokinetics study of food ingredient.(SIC-2020-05-SHKBSE)
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the pharmacokinetics of food ingredient.
Basic objectives2
Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
concentration of food ingredients in blood
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Subjects will take the food (1) once a day. After more than 5 days of washout period, subjects will take the food (2) once a day.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 40 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Male
Key inclusion criteria
(1) Subjects who can make self-judgment and are voluntarily giving written informed consent.
(2) Healthy men and women whose are 40 <= years old < 60. Employees who work at the Suntory World Research Center.
(3) Subject who are scheduled to come to work on designated days.
Key exclusion criteria
(1)Subjects who are with treatment.
(2)Subjects who are with history of gastrointestinal surgery.
(3)Subjects who are attending other studies or attended other studies within the past 4 weeks.
(4)Subjects who are;
a)With present heart disorder, liver disorder, or kidney disorder,
b)With history of cardiac disorder,
c)With diabetes mellitus, or
d)With allergy to the study foods.
(5)Subjects who are not negative for syphilis, HBs antigen, HCV antibody, HIV antigen/antibody or HTLV-1/2 antibody test.
(6)Subjects who are deemed to be unsuitable by the investigator.
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | Hiroshi |
| Middle name | |
| Last name | Watanabe |
Organization
Suntory global innovation center limited.
Division name
Research Institute
Zip code
619-0284
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, JAPAN
TEL
050-3182-0593
H_Watanabe@suntory.co.jp
Public contact
Name of contact person
| 1st name | Mariko |
| Middle name | |
| Last name | Sato |
Organization
Suntory global innovation center limited.
Division name
Research Institute
Zip code
619-0284
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, JAPAN
TEL
050-3182-0954
Homepage URL
Mariko_Sato@suntory.co.jp
Sponsor or person
Institute
Suntory global innovation center limited.
Institute
Department
Personal name
Funding Source
Organization
Suntory global innovation center limited.
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Miura Clinic, Medical Corporation Kanonkai
Address
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka
Tel
06-6135-5200
info@miura-cl.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 10 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2020 | Year | 09 | Month | 17 | Day |
Date of IRB
| 2020 | Year | 09 | Month | 17 | Day |
Anticipated trial start date
| 2020 | Year | 10 | Month | 28 | Day |
Last follow-up date
| 2021 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2020 | Year | 10 | Month | 13 | Day |
Last modified on
| 2024 | Year | 10 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048041
